Видео ютуба по тегу Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals: RNAi Therapies for Obesity
Arrowhead Pharmaceuticals: RNAi Therapies for Obesity
Novartis x Arrowhead? The RNAi Deal That Could Reshape Cardiometabolic Pharma
Novartis x Arrowhead? The RNAi Deal That Could Reshape Cardiometabolic Pharma
ARWR August Outlook | Is Arrowhead About to Break the Silence on RAGE?
ARWR August Outlook | Is Arrowhead About to Break the Silence on RAGE?
Arrowhead Pharmaceuticals New Verona Campus - Hooper Corporation
Arrowhead Pharmaceuticals New Verona Campus - Hooper Corporation
Arrowhead Pharmaceuticals (ARWR): Hidden Biotech Gem or Overhyped?
Arrowhead Pharmaceuticals (ARWR): Hidden Biotech Gem or Overhyped?
Arrowhead CEO breaks down drug partnerships with Johnson & Johnson and Amgen
Arrowhead CEO breaks down drug partnerships with Johnson & Johnson and Amgen
(ARWR) Arrowhead pharmaceuticals stock analysis, why the technology is inferior
(ARWR) Arrowhead pharmaceuticals stock analysis, why the technology is inferior
Arrowhead Pharmaceuticals: RNAi Launch & Valuation ARWR $ARWR #ARWR #finance #stockmarket #investing
Arrowhead Pharmaceuticals: RNAi Launch & Valuation ARWR $ARWR #ARWR #finance #stockmarket #investing
Arrowhead Pharmaceuticals breaks ground in Verona
Arrowhead Pharmaceuticals breaks ground in Verona
Could This New FDA Voucher Fast-Track Arrowhead’s Drugs?
Could This New FDA Voucher Fast-Track Arrowhead’s Drugs?
Arrowhead Pharmaceuticals FDA Approval of REDEMPLO® | Nov 18, 2025
Arrowhead Pharmaceuticals FDA Approval of REDEMPLO® | Nov 18, 2025
Inside RNAi with Arrowhead Pharmaceuticals' Javier San Martin
Inside RNAi with Arrowhead Pharmaceuticals' Javier San Martin
Arrowhead Pharmaceuticals Inc (ARWR) Stock Company Information
Arrowhead Pharmaceuticals Inc (ARWR) Stock Company Information
Beyond the PDUFA: What’s Next in Arrowhead’s Pipeline?
Beyond the PDUFA: What’s Next in Arrowhead’s Pipeline?
Arrowhead vs Alnylam vs Ionis: RNA Therapeutics Showdown (2025 Analysis)
Arrowhead vs Alnylam vs Ionis: RNA Therapeutics Showdown (2025 Analysis)
Arrowhead Pharmaceuticals (ARWR Stock), 1st FDA Approved Medication Redemplo Triglyceride reduction
Arrowhead Pharmaceuticals (ARWR Stock), 1st FDA Approved Medication Redemplo Triglyceride reduction
Olezarsen vs. Plozasiran: The RNAi Race in FCS and SHTG
Olezarsen vs. Plozasiran: The RNAi Race in FCS and SHTG
Arrowhead Pharma's $829M Revenue Beat & 23% Stock Surge Explained!
Arrowhead Pharma's $829M Revenue Beat & 23% Stock Surge Explained!
Founder Stories: Christopher Anzalone, CEO of Arrowhead Pharmaceuticals & RNAi Beyond The Liver
Founder Stories: Christopher Anzalone, CEO of Arrowhead Pharmaceuticals & RNAi Beyond The Liver
Arrowhead Pharmaceuticals: Strategy, Cash Runway, and What Comes Next
Arrowhead Pharmaceuticals: Strategy, Cash Runway, and What Comes Next